Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs.

Darshan Mehta Matthew Davis Andrew J EpsteinBrian WenselTodd GrinnellG Rhys Williams

Published in: ClinicoEconomics and outcomes research : CEOR (2021)

Initiation of ESL as 1L monotherapy was associated with statistically significantly greater reductions in any use of several all-cause and FS-related services, number of visits, and charges compared to initiation of a generic ASD as 1L monotherapy in patients with FS. Initiation of a generic ASD as 1L monotherapy was associated with significantly smaller increases in total prescription charges and ASD-related prescription charges.

Keyphrases

autism spectrum disorder
combination therapy
open label
attention deficit hyperactivity disorder
intellectual disability
healthcare
primary care
mental health
type diabetes
randomized controlled trial
metabolic syndrome
insulin resistance
drug induced
working memory